Genflow Biosciences plc (GENF.L)
GBp 1.53
(0.0%)
GBp 1.53
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2021 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 1034.00 | 130.00 | - | - |
| Gross Profit | -1034.00 | -130.00 | - | - |
| Operating Expenses | 1.79 Million | 1.33 Million | 938.09 Thousand | 650.89 Thousand |
| Selling, General and Administrative Expenses | 837.21 Thousand | 665.14 Thousand | 666.65 Thousand | 649.92 Thousand |
| Research and Development Expenses | 960.31 Thousand | 724.46 Thousand | 86.04 Thousand | 93.86 Thousand |
| Other Expenses | - | -54.66 Thousand | 185.4 Thousand | - |
| Cost and Expenses | 1.79 Million | 1.33 Million | 938.09 Thousand | 650.89 Thousand |
| Operating Income | -1.79 Million | -1.33 Million | -988.09 Thousand | -649.92 Thousand |
| Interest Expense | - | 382.00 | 99.00 | - |
| Income Tax Expense | -4.00 | 1.00 | 99.00 | -1086.00 |
| Earnings before Tax | -1.62 Million | -1.33 Million | -988.19 Thousand | -651 Thousand |
| Net Income | -1.62 Million | -1.33 Million | -988.29 Thousand | -651 Thousand |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.00 | -0.82 |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.00 | -0.82 |
| Weighted Average Shares Outstanding | 292.5 Million | 292.5 Million | 292.5 Million | 796.1 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 292.5 Million | 292.5 Million | 292.5 Million | 796.1 Thousand |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -1.79 Million | -1.33 Million | -988.09 Thousand | -1086.00 |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | -97.03 Thousand | - | -97.03 Thousand | 97.03 Thousand | 97.03 Thousand | - |
| Cost of Revenue | 621.00 | 1034.00 | - | 413.00 | - | 130.00 |
| Gross Profit | -97.65 Thousand | -1034.00 | -97.03 Thousand | 96.62 Thousand | 97.03 Thousand | -130.00 |
| Operating Expenses | 982.46 Thousand | 1.79 Million | 406.61 Thousand | 815.06 Thousand | 407.73 Thousand | 1.33 Million |
| Selling, General and Administrative Expenses | 437.3 Thousand | - | 491.54 Thousand | 399.9 Thousand | 407.73 Thousand | - |
| Research and Development Expenses | 545.15 Thousand | - | 207.57 Thousand | 415.15 Thousand | 207.57 Thousand | - |
| Other Expenses | - | - | - | - | - | -54.66 Thousand |
| Cost and Expenses | 983.08 Thousand | 1.79 Million | 406.61 Thousand | 815.47 Thousand | 407.73 Thousand | 1.33 Million |
| Operating Income | -983.08 Thousand | -1.79 Million | -503.64 Thousand | -815.48 Thousand | -310.7 Thousand | -1.33 Million |
| Interest Expense | - | - | - | - | - | 382.00 |
| Income Tax Expense | -1.00 | -4.00 | - | -3.00 | - | 1.00 |
| Earnings before Tax | -1 Million | -1.62 Million | -503.58 Thousand | -621.53 Thousand | -310.77 Thousand | -1.33 Million |
| Net Income | -1 Million | -1.62 Million | -503.58 Thousand | -621.53 Thousand | -310.77 Thousand | -1.33 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 292.5 Million | 292.5 Million | 292.44 Million | 292.5 Million | 292.62 Million | 292.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 292.5 Million | 292.5 Million | 292.3 Million | 292.5 Million | 292.5 Million | 292.5 Million |
| Gross Margin | 1.01 | - | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | 10.12 | - | 5.19 | -8.40 | -3.20 | - |
| Profit Margin | 10.38 | - | 5.19 | -6.41 | -3.20 | - |
| EBITDA | -982.46 Thousand | - | -503.33 Thousand | -815.07 Thousand | -310.49 Thousand | - |
| Earnings Before Tax Margin | 10.13 | - | 5.19 | -8.40 | -3.20 | - |
VVIVF
112040
9262
ZFSTEERING
FE
P4N